Founding Partners
Shanghai Zigang Enterprise Management Co., Ltd.
Dr. Leng Chunsheng, founder of Shanghai Zigang Enterprise Management Co., Ltd. is a prominent leader in China's recombinant protein and peptide drug fields. With nearly 30 years of experience in biopharmaceutical R&D, large-scale industrialization, product commercialization, and corporate management, Dr. Leng has spearheaded the research, development, and production of numerous gene recombinant human insulin products in China, all with independent intellectual property rights. He has been awarded second place in the State Scientific and Technological Progress Award, honored as a National Model Worker, and is a recipient of the State Council's Special Allowance.
Dongbao Enterprise Group Co.,Ltd.
Established in 1985, Dongbao Enterprise Group Co., Ltd. operates within the innovative biomedical industry. Its subsidiaries include Tonghua Dongbao Pharmaceutical Co., Ltd. (SH.600867), as well as several other pharmaceutical enterprises. With nearly 40 years of successful operation, Dongbao Enterprise Group has accumulated closed-loop management expertise, implemented industrial incubation, and helped each invested enterprise grow into an industry leader. Mr. Li Jiahong, the current chairman of the board, also serves as the chairman of Tonghua Dongbao Pharmaceutical. Mr. Li graduated from Fresenius University, Germany.
Founding Partners
Shanghai Zigang Enterprise Management Co., Ltd.
Dr. Leng Chunsheng, founder of Shanghai Zigang Enterprise Management Co., Ltd. is a prominent leader in China's recombinant protein and peptide drug fields. With nearly 30 years of experience in biopharmaceutical R&D, large-scale industrialization, product commercialization, and corporate management, Dr. Leng has spearheaded the research, development, and production of numerous gene recombinant human insulin products in China, all with independent intellectual property rights. He has been awarded second place in the State Scientific and Technological Progress Award, honored as a National Model Worker, and is a recipient of the State Council's Special Allowance.
Dongbao Enterprise Group Co.,Ltd.
Established in 1985, Dongbao Enterprise Group Co., Ltd. operates within the innovative biomedical industry. Its subsidiaries include Tonghua Dongbao Pharmaceutical Co., Ltd. (SH.600867), as well as several other pharmaceutical enterprises. With nearly 40 years of successful operation, Dongbao Enterprise Group has accumulated closed-loop management expertise, implemented industrial incubation, and helped each invested enterprise grow into an industry leader. Mr. Li Jiahong, the current chairman of the board, also serves as the chairman of Tonghua Dongbao Pharmaceutical. Mr. Li graduated from Fresenius University, Germany.